bolus followed by an infusion). This would inform clinical practice and dosing for major surgical procedures.
developed to predict the impact of surgical alteration of AAG levels (an acute phase protein) on total levo-bupivacaine concentrations. Blood samples were obtained at predetermined intervals up to 72 hours and total plasma levels of levo-bupivacaine and AAG were analysed. Population pharmacokinetic modelling was carried out to analyse the generated clinical data (total levo-bupivacaine and AAG) using NONMEM7.3 (ICON plc, Dublin, Ireland).
Complete results were obtained from 6-out-of-8 patients. Maximum plasma level of total levo-bupivacaine at 1 hour was 0.7 mg/ml. (range¼0.20e0.7). Maximum total levo-bupivacaine observed at 48 hours was 1.85 mg/ml (range¼0.07e1.85). Serum AAG levels also continued to rise up to 72 hours. But, the simulated unbound levo-bupivacaine levels, based on the current model, suggests that unbound levo-bupivacaine quickly reaches steady state concentrations following the loading dose and is maintained at a constant level of around 0.03mg/ml throughout the infusion period (Fig. 3) .
This trial validates the pharmacokinetic model and we conclude that in-spite of the increase in total levo-bupivacaine over 48hours, due to the increase in AAG, the unbound levobupivacaine level is maintained at a steady state, well below the predicted toxic levels. Elective Hip And Knee Arthroplasty (HAKA) audit looking at anaesthetic technique, postop pain scores, nausea, vomiting, first mobilisation times, patient satisfaction and days until discharge prior to the implementation of an enhanced recovery pathway at Pilgrim Hospital Demand is increasing for elective hip and knee arthroplasties. At Pilgrim Hospital, no consensus existed for the preferred anaesthetic technique. The balance is between anaesthetic technique, good post-op analgesia and early mobilisation. The shared goal is ultimately a good patient journey and early discharge. Enhanced recovery pathways for hip and knee arthroplasties are being used in other hospitals nationwide and their effectiveness studied 1, 2, 3 . The aim of this audit is to provide evidence of current management and to roll-out an enhanced recovery pathway. This is a prospective data collection of elective Hip and Knee arthroplasties. Over 11/5/16 to 16/6/16. We included patients receiving Spinals (with or without diamorphine) and general anaesthesia (with or without regional blocks which included femoral, sciatic and/or iliac). We collected: visual analogue pain scores (0e10) in recovery and every six hours for three days; incidence of nausea and vomiting; time until first mobilisation; patient satisfaction and days until discharge. We used a data collection form and 'WebV' electronic system. Total 52 patients. 28 Hips (7 Revisions). 24 Knees (1 Revision). Average age 70 yrs and ASA 2. For full results see Table 2 . Morphine patient controlled analgesia (PCA) was used for 25 patients with similar usage on day 1 of 19 mg average and satisfaction rating of 'good/very good'. Without PCA it was 'good' despite comparatively less oral morphine. Mobilisation and discharge was delayed for 1) Knees with PCA vs oral morphine (not apply to hips) 2) Hip and knees with blocks. With blocks post-op analgesic requirements were higher with higher pain scores and worse patient satisfaction. Pain, mobilisation and discharge with diamorphine in spinals is comparable to those spinals without diamorphine but incidence of nausea is more with diamorphine. Primary vs revisions: Hip mobilisation and discharge is comparable but for knees is longer for revisions.
There are some limitations such as sample size. Pain scores are subjective and occasionally retrospective which limits their comparison. PCA dose documentation varied. There were three post-op complications reducing weight of discharge data. Experience of operator for regional block not collected. Incidence of Urinary retention not collected.
Incidence and outcome of anaphylaxis in cardiac surgical patients e should we proceed to cardiopulmonary bypass and complete surgery? Anaphylaxis is defined as a severe, potentially life threatening systemic hypersensitivity reaction. 1 The incidence of peri-operative anaphylaxis is approximately 1:10,000e20,000 anaesthetic procedures. 2 Anaphylaxis in patients with cardiac disease is likely to pose added risk of adverse outcome. Cardiac surgery is unique because there is the opportunity for immediate cardio-respiratory support using bypass (CPB) following an anaphylactic event. One could propose that all cardiac surgical patients undergoing anaphylaxis should be supported with CPB until stability is established. However, a secondary decision to then proceed to completion of surgery is more difficult. The sixth National Audit Project (NAP6) is collecting information on perioperative anaphylactic events in order to make recommendations to improve patient care. 3 The aim was to investigate the incidence and management of anaphylaxis in cardiac surgical patients.
Retrospective case note review of cardiac surgical patients reported to have had an anaphylactic reaction over a period of 20 years (1997e2017). Data collected included age at time of event, gender, cause (after allergy testing), type of surgery, location (Anaesthetic room or theatre), onset time, need for CPR, decision to continue with surgery, time for reoperation, 90-day survival, time taken to be reviewed in allergy clinic. 17 peri-operative anaphylaxis incidents were reported amongst 17589 patients (0.1%). Most (76%) occurred within 30 minutes of induction of anaesthesia with 7 (41%) of the 17 proceeding to completion of planned surgery.
We found a greater incidence of anaphylaxis in our cardiac patients compared to the general anaesthetic population. However, it will be interesting to see the results of NAP6, because this may be due to differences in reporting. We are unaware of any consensus or recommendations for continuing to cardiac surgery following anaphylaxis. Some, that occurred either pre-or during bypass, were postponed whilst others (41%) proceeded to completion of intended operation e this 41% having good outcomes. The delay in reoperation in some of those postponed was very prolonged. The reasons for postponement were not investigated. However, management of anaphylaxis for patients undergoing cardiac surgery pose interesting dilemmas, which need further review. . V E /VCO 2 slope (measured from start of exercise to the respiratory compensation point) theoretically offers an advantage over V E /VCO 2 (measured at a single point in time which may itself be difficult to identify reliably) and has demonstrated clinical utility in heart failure prognostication and in valvular heart disease. 3 There are no studies to date investigating the use of V E /VCO 2 slope in preoperative assessment and patient outcomes following major surgery. This study compares measured V E /VCO 2 slope with V E /VCO 2 AT in a cohort of patients undergoing major abdominal surgery and their association with postoperative mortality. Routine preoperative CPET performed in 917 surgical patients (M/F 565/352, mean age 69.1 yr) at our institution between Feb 2012 and Dec 2014, were retrospectively examined to ascertain the following parameters: V E /VCO 2 slope between start of exercise and the respiratory compensation point and 
